The pruritus drug pipeline focuses on novel antipruritic agents, including opioid receptor modulators and cytokine inhibitors, aiming to relieve chronic and refractory itching. https://www.expertmarketresearch.com/clinical-trials/pruritus-drug-pipeline-insight